In nearly 209,000 matched adults with type 2 diabetes, diagnoses were 0.15% on GLP-1s versus 0.10% on DPP-4 inhibitors. Authors call it a signal needing confirmation.
Recap by typeshit. Full story at BIOENGINEER.
MedPage Today
A JAMA Network Open analysis of Reddit posts also lists fatigue, insomnia and muscle symptoms. MedPage's roundup adds a CagriSema menopause analysis and Walmart's GLP-1 coverage plan.
A short teaser comparing how well people tolerate the two main GLP-1 ingredients, with the full breakdown behind the link.
Doctors quoted by Men's Journal raise concerns about how much GLP-1 users are paying for add-on supplements each month.
The anti-doping agency says many sellers use research chemical labels to dodge FDA scrutiny while selling peptides and SARMs.
The lab is looking for people about to begin, or planning to stop, drugs like Ozempic, Wegovy or Zepbound to study effects on the brain.
2:58
A simple breakdown of how tirzepatide acts on two hormone pathways while retatrutide acts on three, from a pharmacist's channel.
Loading…